LEMZOPARLIMAB: 23 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
23
Total FAERS Reports
7 (30.4%)
Deaths Reported
20
Hospitalizations
23
As Primary/Secondary Suspect
6
Life-Threatening
First Report: 20210706 · Latest Report: 20221107
What Are the Most Common LEMZOPARLIMAB Side Effects?
#1 Most Reported
Febrile neutropenia
5 reports (21.7%)
#2 Most Reported
Pneumonia
3 reports (13.0%)
#3 Most Reported
Ankle fracture
3 reports (13.0%)
All LEMZOPARLIMAB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 5 | 21.7% | 0 | 4 |
Who Reports LEMZOPARLIMAB Side Effects? Age & Gender Data
Gender: 63.2% female, 36.8% male. Average age: 63.1 years. Most reports from: CN. View detailed demographics →
Is LEMZOPARLIMAB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2021 | 6 | 4 | 6 |
| 2022 | 16 | 3 | 14 |
What Is LEMZOPARLIMAB Used For?
| Indication | Reports |
|---|---|
| Acute myeloid leukaemia | 16 |
Official FDA Label for LEMZOPARLIMAB
Official prescribing information from the FDA-approved drug label.